245 related articles for article (PubMed ID: 21247819)
1. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study.
Conroy SM; Pagano I; Kolonel LN; Maskarinec G
Cancer Epidemiol; 2011 Oct; 35(5):448-52. PubMed ID: 21247819
[TBL] [Abstract][Full Text] [Related]
2. Mammographic density and risk of breast cancer by age and tumor characteristics.
Bertrand KA; Tamimi RM; Scott CG; Jensen MR; Pankratz V; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
Breast Cancer Res; 2013 Nov; 15(6):R104. PubMed ID: 24188089
[TBL] [Abstract][Full Text] [Related]
3. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
Ma H; Luo J; Press MF; Wang Y; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):479-85. PubMed ID: 19190139
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
5. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
6. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
9. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort.
Gill JK; Maskarinec G; Pagano I; Kolonel LN
Breast Cancer Res; 2006; 8(3):R30. PubMed ID: 16796758
[TBL] [Abstract][Full Text] [Related]
10. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR
Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299
[TBL] [Abstract][Full Text] [Related]
11. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
13. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
[TBL] [Abstract][Full Text] [Related]
14. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
15. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
16. A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.
Kohail HM; Elias EG; el-Nowiem SA; Bashirelahi N; Didolkar MS; Reed WP
Ann Surg; 1985 May; 201(5):611-7. PubMed ID: 2986565
[TBL] [Abstract][Full Text] [Related]
17. Mammographic density and breast cancer risk: the multiethnic cohort study.
Maskarinec G; Pagano I; Lurie G; Wilkens LR; Kolonel LN
Am J Epidemiol; 2005 Oct; 162(8):743-52. PubMed ID: 16150892
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D
J BUON; 2013; 18(3):619-22. PubMed ID: 24065473
[TBL] [Abstract][Full Text] [Related]
19. Hormone-receptor expression and survival patterns in operated cases of female invasive ductal breast carcinoma in Kerala: a retrospective cohort study.
Vettuparambil A; Chirukandath R; Culas TB; Vijayan SM; Rajan G; Kuttappan SV
World J Surg Oncol; 2015 Apr; 13():160. PubMed ID: 25899789
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]